07:00 , May 5, 1997 |  BC Week In Review  |  Company News

Camelot Pharmacal, Sheffield Medical Technologies Inc. deal

SHM acquired Camelot for 600,000 shares of common stock plus options to acquire 1.2 million common shares of SHM issued to the Camelot management team. SHM has 11 million shares outstanding. (See Management Tracks, B7.)...
08:00 , Mar 24, 1997 |  BC Week In Review  |  Company News

Camelot Pharmacal L.L.C., Sheffield Medical Technologies Inc. deal

SHM signed a letter of intent to acquire Camelot, a privately held pharmaceutical company, for an undisclosed amount. Products and indications were not disclosed. SHM and its Ion Pharmaceuticals Inc. subsidiary (Boston, Mass.) are developing...